A citation-based method for searching scientific literature

Gabriela Leuschner, Jürgen Behr. Front Med (Lausanne) 2017
Times Cited: 54







List of co-cited articles
321 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
539
50

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
35

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
35

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
428
27

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
27

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.
Takafumi Suda, Yusuke Kaida, Yutaro Nakamura, Noriyuki Enomoto, Tomoyuki Fujisawa, Shiro Imokawa, Hideo Hashizume, Tateaki Naito, Dai Hashimoto, Yasuo Takehara,[...]. Respir Med 2009
136
25

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
I-Nae Park, Dong Soon Kim, Tae Sun Shim, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Won Dong Kim, Se Jin Jang, Thomas V Colby. Chest 2007
211
25

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
22

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
14

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
731
14

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
430
14

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.
D S Kim, J H Park, B K Park, J S Lee, A G Nicholson, T Colby. Eur Respir J 2006
307
12

Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease.
Yuko Toyoda, Masaki Hanibuchi, Jun Kishi, Hiroshi Kawano, Shun Morizumi, Seidai Sato, Mayo Kondo, Terumi Takikura, Toshifumi Tezuka, Hisatsugu Goto,[...]. J Med Invest 2016
26
26


Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
404
12

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
161
12

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
11

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
928
11

A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia.
Yutaka Usui, Akiko Kaga, Fumikazu Sakai, Ayako Shiono, Ken-Ichiro Komiyama, Koichi Hagiwara, Minoru Kanazawa. BMJ Open 2013
33
18

Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Ryo Tachikawa, Keisuke Tomii, Hiroyuki Ueda, Kazuma Nagata, Shigeki Nanjo, Ayako Sakurai, Kyoko Otsuka, Reiko Kaji, Michio Hayashi, Nobuyuki Katakami,[...]. Respiration 2012
77
11

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
447
11

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Noriyuki Enomoto, Yoshiyuki Oyama, Yasunori Enomoto, Hideki Yasui, Masato Karayama, Masato Kono, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa,[...]. Chron Respir Dis 2019
17
35

Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
Virginie Simon-Blancal, Olivia Freynet, Hilario Nunes, Diane Bouvry, Nicolas Naggara, Pierre-Yves Brillet, Damien Denis, Yves Cohen, François Vincent, Dominique Valeyre,[...]. Respiration 2012
87
9

High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
Fumiko Tomiyama, Ryu Watanabe, Tomonori Ishii, Yukiko Kamogawa, Yoko Fujita, Yuko Shirota, Koichiro Sugimura, Hiroshi Fujii, Hideo Harigae. Tohoku J Exp Med 2016
21
23

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study.
Hironao Hozumi, Yutaro Nakamura, Takeshi Johkoh, Hiromitsu Sumikawa, Thomas V Colby, Masato Kono, Dai Hashimoto, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui,[...]. BMJ Open 2013
74
9

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
9


Acute exacerbations of progressive-fibrosing interstitial lung diseases.
Martin Kolb, Benjamin Bondue, Alberto Pesci, Yasunari Miyazaki, Jin Woo Song, Nitin Y Bhatt, John T Huggins, Justin M Oldham, Maria L Padilla, Jesse Roman,[...]. Eur Respir Rev 2018
57
9

Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.
Jürgen Behr, Petra Neuser, Antje Prasse, Michael Kreuter, Klaus Rabe, Carmen Schade-Brittinger, Jasmin Wagner, Andreas Günther. BMC Pulm Med 2017
55
7

Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Toby M Maher, Tamera J Corte, Clare R Sander, Jonathan Ratoff, Anand Devaraj,[...]. Am J Respir Crit Care Med 2008
582
7

Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.
Aryeh Fischer, Kevin K Brown, Roland M Du Bois, Stephen K Frankel, Gregory P Cosgrove, Evans R Fernandez-Perez, Tristan J Huie, Mahalakshmi Krishnamoorthy, Richard T Meehan, Amy L Olson,[...]. J Rheumatol 2013
192
7

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
392
7

High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.
Jean-Pierre Frat, Arnaud W Thille, Alain Mercat, Christophe Girault, Stéphanie Ragot, Sébastien Perbet, Gwénael Prat, Thierry Boulain, Elise Morawiec, Alice Cottereau,[...]. N Engl J Med 2015
893
7

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Christopher J Ryerson, Vincent Cottin, Kevin K Brown, Harold R Collard. Eur Respir J 2015
91
7

Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease.
Mineto Ota, Yukiko Iwasaki, Hiroaki Harada, Oh Sasaki, Yasuo Nagafuchi, Shinichiro Nakachi, Shuji Sumitomo, Hirofumi Shoda, Shigeto Tohma, Keishi Fujio,[...]. Mod Rheumatol 2017
19
21

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis.
Keishi Oda, Hiroshi Ishimoto, Sohsuke Yamada, Hisako Kushima, Hiroshi Ishii, Tomotoshi Imanaga, Tatsuhiko Harada, Yuji Ishimatsu, Nobuhiro Matsumoto, Keisuke Naito,[...]. Respir Res 2014
48
8

Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
Alessandro Marchioni, Roberto Tonelli, Lorenzo Ball, Riccardo Fantini, Ivana Castaniere, Stefania Cerri, Fabrizio Luppi, Mario Malerba, Paolo Pelosi, Enrico Clini. Crit Care 2018
29
13

Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
Sandra Chartrand, Jeffrey J Swigris, Lina Stanchev, Joyce S Lee, Kevin K Brown, Aryeh Fischer. Respir Med 2016
69
7


High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
Spyros A Papiris, Ioannis P Tomos, Anna Karakatsani, Aris Spathis, Ioanna Korbila, Antonis Analitis, Likurgos Kolilekas, Konstantinos Kagouridis, Stylianos Loukides, Petros Karakitsos,[...]. Cytokine 2018
57
7

Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.
Andreina Manfredi, Marco Sebastiani, Stefania Cerri, Caterina Vacchi, Roberto Tonelli, Giovanni Della Casa, Giulia Cassone, Amelia Spinella, Pancaldi Fabrizio, Fabrizio Luppi,[...]. J Thorac Dis 2019
22
18


Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Michael D Roth, Daniel E Furst, Richard M Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B Bolster,[...]. Am J Respir Crit Care Med 2007
268
7


Telomere length and genetic variant associations with interstitial lung disease progression and survival.
Chad A Newton, Justin M Oldham, Brett Ley, Vikram Anand, Ayodeji Adegunsoye, Gabrielle Liu, Kiran Batra, Jose Torrealba, Julia Kozlitina, Craig Glazer,[...]. Eur Respir J 2019
56
7

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Vincent Cottin, Nikhil A Hirani, David L Hotchkin, Anoop M Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K Poonyagariyagorn, Wim Wuyts,[...]. Eur Respir Rev 2018
131
7

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
5

Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.
Patrick Huppmann, Bernd Sczepanski, Martina Boensch, Sandra Winterkamp, Ursula Schönheit-Kenn, Claus Neurohr, Juergen Behr, Klaus Kenn. Eur Respir J 2013
83
5

[German guideline for diagnosis and management of idiopathic pulmonary fibrosis].
J Behr, A Günther, W Ammenwerth, I Bittmann, R Bonnet, R Buhl, O Eickelberg, R Ewert, S Gläser, J Gottlieb,[...]. Pneumologie 2013
31
9

Lung Manifestations in the Rheumatic Diseases.
Tracy J Doyle, Paul F Dellaripa. Chest 2017
50
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.